These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32322109)

  • 21. Trastuzumab-containing regimens for metastatic breast cancer.
    Balduzzi S; Mantarro S; Guarneri V; Tagliabue L; Pistotti V; Moja L; D'Amico R
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD006242. PubMed ID: 24919460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Major changes in chemotherapy regimens administered to breast cancer patients during 2000-2008 in the Netherlands.
    van Herk-Sukel MP; van de Poll-Franse LV; Creemers GJ; Lemmens VE; van der Linden PD; Herings RM; Coebergh JW; Voogd AC
    Breast J; 2013; 19(4):394-401. PubMed ID: 23663128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis, Therapy and Follow-up Care of Vulvar Cancer and its Precursors. Guideline of the DGGG and DKG (S2k-Level, AWMF Registry Number 015/059, November 2015.
    Schnürch HG; Ackermann S; Alt CD; Barinoff J; Böing C; Dannecker C; Gieseking F; Günthert A; Hantschmann P; Horn LC; Kürzl R; Mallmann P; Marnitz S; Mehlhorn G; Hack CC; Koch MC; Torsten U; Weikel W; Wölber L; Hampl M
    Geburtshilfe Frauenheilkd; 2016 Oct; 76(10):1035-1049. PubMed ID: 27765958
    [No Abstract]   [Full Text] [Related]  

  • 24. A phase III trial of exemestane plus bevacizumab maintenance therapy in patients with metastatic breast cancer after first-line taxane and bevacizumab: a GINECO group study.
    Trédan O; Follana P; Moullet I; Cropet C; Trager-Maury S; Dauba J; Lavau-Denes S; Diéras V; Béal-Ardisson D; Gouttebel M; Orfeuvre H; Stefani L; Jouannaud C; Bürki F; Petit T; Guardiola E; Becuwe C; Blot E; Pujade-Lauraine E; Bachelot T
    Ann Oncol; 2016 Jun; 27(6):1020-1029. PubMed ID: 26916095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HER2-targeted treatment for older patients with breast cancer: An expert position paper from the International Society of Geriatric Oncology.
    Brain E; Caillet P; de Glas N; Biganzoli L; Cheng K; Lago LD; Wildiers H
    J Geriatr Oncol; 2019 Nov; 10(6):1003-1013. PubMed ID: 31235436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ixabepilone as monotherapy or in combination with capecitabine for the treatment of advanced breast cancer.
    Rak Tkaczuk KH
    Breast Cancer (Auckl); 2011 Jan; 5():1-14. PubMed ID: 21494397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. If there is no overall survival benefit in metastatic breast cancer: does it imply lack of efficacy? Taxanes as an example.
    Vriens BE; Lobbezoo DJ; de Hoon JP; Veeck J; Voogd AC; Tjan-Heijnen VC
    Cancer Treat Rev; 2013 Apr; 39(2):189-98. PubMed ID: 22658318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormonal therapy might be a better choice as maintenance treatment than capecitabine after response to first-line capecitabine-based combination chemotherapy for patients with hormone receptor-positive and HER2-negative, metastatic breast cancer.
    Chen XL; Du F; Hong RX; Wang JY; Luo Y; Li Q; Fan Y; Xu BH
    Chin J Cancer; 2016 Apr; 35():39. PubMed ID: 27112139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Recommendations of DEGRO and AGO on Preferred Standard Palliative Radiotherapy of Bone and Cerebral Metastases, Metastatic Spinal Cord Compression, and Leptomeningeal Carcinomatosis in Breast Cancer.
    Souchon R; Feyer P; Thomssen C; Fehm T; Diel I; Nitz U; Janni W; Bischoff J; Sauer R
    Breast Care (Basel); 2010 Dec; 5(6):401-7. PubMed ID: 21494406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Nummer 032/034-OL, April 2018) - Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer.
    Emons G; Steiner E; Vordermark D; Uleer C; Bock N; Paradies K; Ortmann O; Aretz S; Mallmann P; Kurzeder C; Hagen V; van Oorschot B; Höcht S; Feyer P; Egerer G; Friedrich M; Cremer W; Prott FJ; Horn LC; Prömpeler H; Langrehr J; Leinung S; Beckmann MW; Kimmig R; Letsch A; Reinhardt M; Alt-Epping B; Kiesel L; Menke J; Gebhardt M; Steinke-Lange V; Rahner N; Lichtenegger W; Zeimet A; Hanf V; Weis J; Mueller M; Henscher U; Schmutzler RK; Meindl A; Hilpert F; Panke JE; Strnad V; Niehues C; Dauelsberg T; Niehoff P; Mayr D; Grab D; Kreißl M; Witteler R; Schorsch A; Mustea A; Petru E; Hübner J; Rose AD; Wight E; Tholen R; Bauerschmitz GJ; Fleisch M; Juhasz-Boess I; Sigurd L; Runnebaum I; Tempfer C; Nothacker MJ; Blödt S; Follmann M; Langer T; Raatz H; Wesselmann S; Erdogan S
    Geburtshilfe Frauenheilkd; 2018 Oct; 78(10):949-971. PubMed ID: 30364388
    [No Abstract]   [Full Text] [Related]  

  • 31. Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma.
    Zelek L; Barthier S; Riofrio M; Fizazi K; Rixe O; Delord JP; Le Cesne A; Spielmann M
    Cancer; 2001 Nov; 92(9):2267-72. PubMed ID: 11745280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Taxane containing regimens for metastatic breast cancer.
    Ghersi D; Wilcken N; Simes J; Donoghue E
    Cochrane Database Syst Rev; 2003; (3):CD003366. PubMed ID: 12917963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Taxane containing regimens for metastatic breast cancer.
    Ghersi D; Wilcken N; Simes J; Donoghue E
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003366. PubMed ID: 15846659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rationale and use of epirubicin-based therapy in the adjuvant setting.
    Mouridsen HT
    Clin Breast Cancer; 2000 Sep; 1 Suppl 1():S34-40. PubMed ID: 11970748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial.
    Park YH; Kim TY; Kim GM; Kang SY; Park IH; Kim JH; Lee KE; Ahn HK; Lee MH; Kim HJ; Kim HJ; Lee JI; Koh SJ; Kim JY; Lee KH; Sohn J; Kim SB; Ahn JS; Im YH; Jung KH; Im SA;
    Lancet Oncol; 2019 Dec; 20(12):1750-1759. PubMed ID: 31668850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of bevacizumab combined with chemotherapy in the treatment of HER2-negative metastatic breast cancer: a network meta-analysis.
    Sun Z; Lan X; Xu S; Li S; Xi Y
    BMC Cancer; 2020 Mar; 20(1):180. PubMed ID: 32131770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of advanced breast cancer with the epothilone B analog, ixabepilone.
    Gradishar W
    Drug Des Devel Ther; 2009 Sep; 3():163-71. PubMed ID: 19920932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II, Multicenter, Single-arm Trial of Eribulin as First-line Therapy for Patients With Aggressive Taxane-pretreated HER2-Negative Metastatic Breast Cancer: The MERIBEL Study.
    Ortega V; Antón A; Garau I; Afonso N; Calvo L; Fernández Y; Martínez-García M; Blanco E; Zamora P; García M; Illarramendi JJ; Rodríguez Sánchez CA; Sampayo M; Aguirre E; Pérez-García JM; Cortés J; Llombart-Cussac A
    Clin Breast Cancer; 2019 Apr; 19(2):105-112. PubMed ID: 30679100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response rates of taxane rechallenge in metastatic breast cancer patients previously treated with adjuvant taxanes.
    Kucukoztas N; Oguz A; Rahatli S; Altundag O; Altundag K
    J BUON; 2016; 21(5):1076-1081. PubMed ID: 27837607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Taxane versus vinorelbine in combination with trastuzumab and pertuzumab for first-line treatment of metastatic HER2-positive breast cancer: a retrospective two-center study.
    Reinhorn D; Kuchuk I; Shochat T; Nisenbaum B; Sulkes A; Hendler D; Rotem O; Tsoref D; Olitzky O; Goldvaser H; Sarfaty M; Neiman V; Prus J; Gottfried M; Yust-Katz S; Yerushalmi R
    Breast Cancer Res Treat; 2021 Jul; 188(2):379-387. PubMed ID: 33772709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.